VR Logo

Alembic Pharmaceuticals Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 2010

Chairman: Chirayu Amin

Managing Director: Shaunak Amin

Group: Alembic

Listing: NSE: APLLTD, BSE: 533573

Headquarters: Vadodara, Gujarat

Website: www.alembicpharmaceuticals.com

Key Facts

Market cap: R 19,527.56 Cr

Revenue (TTM): R 5,214.38 Cr

Earnings (TTM): R 1,049.36 Cr

Cash: R 80.74 Cr

Total Debt: R 1,747.49 Cr

Promoters' ownership: 69.77%

Liquidity: High

52 Week range: R 434.80 - 1,128.90

Face value: R2.00

Shares outstanding: 19,65,63,124

10 Years Aggregate:

  • CFO: 3,763.06 Cr
  • EBITDA: 5,664.70 Cr
  • Net Profit: 3,840.21 Cr

Stock Performance

Time Period Alembic Pharmaceuticals S&P BSE Healthcare S&P BSE Mid Cap
YTD73.8953.6714.69
1 month2.747.9814.76
3 months6.799.2414.30
1 Year78.6552.6514.69
3 Years24.6614.170.81
5 Years7.364.429.11
10 Years--11.877.84
As on 02-Dec-2020
Year Alembic Pharmaceuticals S&P BSE Mid Cap S&P BSE Healthcare
2019-2.65-3.05-3.55
201812.95-13.31-5.89
2017-10.8448.130.49
2016-13.487.97-12.88
201556.357.4315.06
2014107.8254.6947.43
2013190.77-5.7322.55